Risk versus Benefit of Tyrosine Kinase Inhibitors for Hepatocellular Carcinoma: A Systematic Review and Meta‐Analysis of Randomized Controlled Trials.

Published in:

Clinical Pharmacology & Therapeutics, 2024, v. 116, n. 2, p. 328, doi. 10.1002/cpt.3312

By:

• Payo‐Serafín, Tania;
• Méndez‐Blanco, Carolina;
• Fernández‐Palanca, Paula;
• Martínez‐Geijo, Jennifer;
• Reviejo, María;
• Ortiz‐de‐Urbina, Juan José;
• González‐Gallego, Javier;
• Marin, Jose J. G.;
• Mauriz, José L.;
• San‐Miguel, Beatriz

Publication type:

Article